Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean M Wingerchuk

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
The Lancet. Neurology|January 24, 2006
OSMS is NMO, but not MS: proven clinically and pathologicallyBrian G Weinshenker, Dean M Wingerchuk, Ichiro Nakashima, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorderDean M Wingerchuk, Brian G Weinshenker, Dana McCormick, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 20, 2021
Reversible Cerebral Vasculopathy, Transverse Myelitis, and Active Systemic Lupus Erythematosus in an Aquaporin-4 Antibody-Positive PatientDavid Gritsch, Amir A Mbonde, Ehab Y Harahsheh, et al.
The Neurologist|July 14, 2022
In Patients With Melanoma Brain Metastases, Is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised TopicDavid Gritsch, Maciej M Mrugala, Lisa A Marks, et al.
The Neurologist|May 15, 2007
Alpha-lipoic acid may improve symptomatic diabetic polyneuropathyJunger Tang, Dean M Wingerchuk, Brian A Crum, et al.
The Neurologist|July 4, 2020
Is Noninvasive Vagus Nerve Stimulation a Safe and Effective Alternative to Medication for Acute Migraine Control?Benzion Blech, Amaal J Starling, Lisa A Marks, et al.
The Neurologist|May 7, 2010
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topicSrijana Zarkou, Jonathan L Carter, Kay E Wellik, et al.
The Neurologist|March 14, 2007
"Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseasesMark G Hickey, Bart M Demaerschalk, Richard J Caselli, et al.
Disease Markers|November 25, 2006
NMO-IgG: a specific biomarker for neuromyelitis opticaBrian G Weinshenker, Dean M Wingerchuk, Sean J Pittock, et al.
The Neurologist|January 10, 2009
Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation: a critically appraised topicAmy C Almaraz, Bentley J Bobrow, Dean M Wingerchuk, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
The Lancet. Neurology|January 24, 2006
OSMS is NMO, but not MS: proven clinically and pathologicallyBrian G Weinshenker, Dean M Wingerchuk, Ichiro Nakashima, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorderDean M Wingerchuk, Brian G Weinshenker, Dana McCormick, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 20, 2021
Reversible Cerebral Vasculopathy, Transverse Myelitis, and Active Systemic Lupus Erythematosus in an Aquaporin-4 Antibody-Positive PatientDavid Gritsch, Amir A Mbonde, Ehab Y Harahsheh, et al.
The Neurologist|July 14, 2022
In Patients With Melanoma Brain Metastases, Is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised TopicDavid Gritsch, Maciej M Mrugala, Lisa A Marks, et al.
The Neurologist|May 15, 2007
Alpha-lipoic acid may improve symptomatic diabetic polyneuropathyJunger Tang, Dean M Wingerchuk, Brian A Crum, et al.
The Neurologist|July 4, 2020
Is Noninvasive Vagus Nerve Stimulation a Safe and Effective Alternative to Medication for Acute Migraine Control?Benzion Blech, Amaal J Starling, Lisa A Marks, et al.
The Neurologist|May 7, 2010
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topicSrijana Zarkou, Jonathan L Carter, Kay E Wellik, et al.
The Neurologist|March 14, 2007
"Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseasesMark G Hickey, Bart M Demaerschalk, Richard J Caselli, et al.
Disease Markers|November 25, 2006
NMO-IgG: a specific biomarker for neuromyelitis opticaBrian G Weinshenker, Dean M Wingerchuk, Sean J Pittock, et al.
The Neurologist|January 10, 2009
Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation: a critically appraised topicAmy C Almaraz, Bentley J Bobrow, Dean M Wingerchuk, et al.
Pageof 19